The Oncology Institute Warrant
TOIIW
TOIIW was delisted on the 31st of July, 2026.
15 hedge funds and large institutions have $52K invested in The Oncology Institute Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 3 closing their positions.
2.28% less ownership
Funds ownership: 5.72% → 3.44% (-2.3%)
17% less funds holding
Funds holding: 18 → 15 (-3)
52% less capital invested
Capital invested by funds: $108K → $52K (-$56K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$32.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$54 |
| 3 |
CS
Clear Street
New York
|
-$10 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$8 |
| 5 |
CAC
Cowen and Company
New York
|
-$8 |
TOIIW Hedge Fund Activity: Q3 2024 in Review
15 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q3 2024, worth a combined $52K — down 52% from $108K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TOIIW and 0 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $32.2K sold.
- 15 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q3 2024, down from 18 in Q2 2024.
- Funds reported $52K of The Oncology Institute Warrant stock for Q3 2024, down 52% quarter-over-quarter.
- 0 funds opened new The Oncology Institute Warrant positions in Q3 2024 and 3 closed out, a net change of -3 holders.
- The largest The Oncology Institute Warrant seller in Q3 2024 was LMR Partners, an estimated $32.2K sold.
Based on aggregated 13F filings for Q3 2024.